Literature DB >> 24323182

Surveillance strategy for rectal neuroendocrine tumors according to recurrence risk stratification.

Dong Hyun Kim1, Jin Ha Lee, Yoon Jin Cha, Soo Jung Park, Jae Hee Cheon, Tae Il Kim, Hoguen Kim, Won Ho Kim, Sung Pil Hong.   

Abstract

BACKGROUND/AIM: Rectal neuroendocrine tumors (NETs) have been increasing in incidence. However, the recommendations for disease surveillance after tumor resection have not been well established. We evaluated the long-term outcomes of rectal NETs and surveillance strategies according to recurrence risk stratification.
METHODS: From January 2000 to July 2011, 188 patients diagnosed with rectal NETs were included in this study. Patient characteristics, treatment methods, recurrence rates, risk factors of recurrence, and surveillance schedules were analyzed.
RESULTS: The male-to-female ratio was 1.29:1 and the mean age at diagnosis was 50.6 years. The mean tumor size was 6.5 (range 1-30) mm. A total of 144 patients (76.6 %) were treated with endoscopic resection, and 44 patients (23.4 %) were treated with surgical resection as the initial treatment. During the follow-up period, ten patients (5.3 %) had disease recurrence, including one case of local recurrence and nine cases of recurrence at a distant site. Tumor size of >10 mm, invasion of the muscularis propria, increased mitotic index, lymphovascular invasion, and regional lymph node metastases were statistically significant predictors of recurrence by univariate analysis. Among the 152 patients without risk factors of recurrence, only one patient who underwent transanal resection had a local recurrence at 15 months after surgery.
CONCLUSION: Our patients with rectal NETs showed favorable clinical outcomes and had a low rate of recurrence. Intensive surveillance with endoscopy or imaging study may not be required in patients without risk factors for recurrence.

Entities:  

Mesh:

Year:  2013        PMID: 24323182     DOI: 10.1007/s10620-013-2972-7

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  18 in total

1.  ENETS Consensus Guidelines for the management of patients with digestive neuroendocrine neoplasms: colorectal neuroendocrine neoplasms.

Authors:  Martyn Caplin; Anders Sundin; Ola Nillson; Richard P Baum; Klaus J Klose; Fahrettin Kelestimur; Ursula Plöckinger; Mauro Papotti; Ramon Salazar; Andreas Pascher
Journal:  Neuroendocrinology       Date:  2012       Impact factor: 4.914

2.  Rectal carcinoids: the most frequent carcinoid tumor.

Authors:  A B Jetmore; J E Ray; J B Gathright; K M McMullen; T C Hicks; A E Timmcke
Journal:  Dis Colon Rectum       Date:  1992-08       Impact factor: 4.585

3.  Criteria for decision making after endoscopic resection of well-differentiated rectal carcinoids with regard to potential lymphatic spread.

Authors:  C H Park; J H Cheon; J O Kim; J E Shin; B I Jang; S J Shin; Y T Jeen; S H Lee; J S Ji; D S Han; S A Jung; D I Park; I H Baek; S H Kim; D K Chang
Journal:  Endoscopy       Date:  2011-07-06       Impact factor: 10.093

4.  Surveillance of small rectal carcinoid tumors in the absence of metastatic disease.

Authors:  Sara E Murray; Rebecca S Sippel; Ricardo Lloyd; Herbert Chen
Journal:  Ann Surg Oncol       Date:  2012-06-16       Impact factor: 5.344

Review 5.  Carcinoids of the rectum.

Authors:  S Mani; I M Modlin; G Ballantyne; H Ahlman; B West
Journal:  J Am Coll Surg       Date:  1994-08       Impact factor: 6.113

6.  An analysis of 8305 cases of carcinoid tumors.

Authors:  I M Modlin; A Sandor
Journal:  Cancer       Date:  1997-02-15       Impact factor: 6.860

7.  Neuroendocrine tumors.

Authors:  Matthew H Kulke; Al B Benson; Emily Bergsland; Jordan D Berlin; Lawrence S Blaszkowsky; Michael A Choti; Orlo H Clark; Gerard M Doherty; James Eason; Lyska Emerson; Paul F Engstrom; Whitney S Goldner; Martin J Heslin; Fouad Kandeel; Pamela L Kunz; Boris W Kuvshinoff; Jeffrey F Moley; Venu G Pillarisetty; Leonard Saltz; David E Schteingart; Manisha H Shah; Stephen Shibata; Jonathan R Strosberg; Jean-Nicolas Vauthey; Rebekah White; James C Yao; Deborah A Freedman-Cass; Mary A Dwyer
Journal:  J Natl Compr Canc Netw       Date:  2012-06-01       Impact factor: 11.908

8.  Carcinoid of the rectum risk stratification (CaRRS): a strategy for preoperative outcome assessment.

Authors:  Bridget N Fahy; Laura H Tang; David Klimstra; W Douglas Wong; Jose G Guillem; Philip B Paty; Larissa K F Temple; Jinru Shia; Martin R Weiser
Journal:  Ann Surg Oncol       Date:  2006-11-09       Impact factor: 5.344

9.  The NANETS consensus guidelines for the diagnosis and management of gastrointestinal neuroendocrine tumors (nets): well-differentiated nets of the distal colon and rectum.

Authors:  Lowell B Anthony; Jonathan R Strosberg; David S Klimstra; William J Maples; Thomas M O'Dorisio; Richard R P Warner; Gregory A Wiseman; Al B Benson; Rodney F Pommier
Journal:  Pancreas       Date:  2010-08       Impact factor: 3.327

Review 10.  Carcinoids of the rectum: an evaluation of 1271 reported cases.

Authors:  J Soga
Journal:  Surg Today       Date:  1997       Impact factor: 2.540

View more
  7 in total

1.  Analysis of the factors affecting lymph node metastasis and the prognosis of rectal neuroendocrine tumors.

Authors:  Peng Li; Fan Wu; Hong Zhao; Lizhou Dou; Yang Wang; Chunguang Guo; Guiqi Wang; Dongbing Zhao
Journal:  Int J Clin Exp Pathol       Date:  2015-10-01

2.  Characteristics and long-term prognosis of patients with rectal neuroendocrine tumors.

Authors:  Yihebali Chi; Feng Du; Hong Zhao; Jin-Wan Wang; Jian-Qiang Cai
Journal:  World J Gastroenterol       Date:  2014-11-21       Impact factor: 5.742

3.  Long-Term Clinical Outcomes of Rectal Neuroendocrine Tumors According to the Pathologic Status After Initial Endoscopic Resection: A KASID Multicenter Study.

Authors:  Chang Mo Moon; Kyu Chan Huh; Sung-Ae Jung; Dong Il Park; Won Hee Kim; Hye Mi Jung; Seong-Joon Koh; Jin-Oh Kim; Yunho Jung; Kyeong Ok Kim; Jong Wook Kim; Dong-Hoon Yang; Jeong Eun Shin; Sung Jae Shin; Eun Soo Kim; Young-Eun Joo
Journal:  Am J Gastroenterol       Date:  2016-07-05       Impact factor: 10.864

4.  Natural course of an untreated metastatic perirectal lymph node after the endoscopic resection of a rectal neuroendocrine tumor.

Authors:  Sang Hyung Kim; Dong-Hoon Yang; Jung Su Lee; Soyoung Park; Ho-Su Lee; Hyojeong Lee; Sang Hyoung Park; Kyung-Jo Kim; Byong Duk Ye; Jeong-Sik Byeon; Seung-Jae Myung; Suk-Kyun Yang; Jin-Ho Kim; Chan Wook Kim; Jihun Kim
Journal:  Intest Res       Date:  2015-04-27

5.  Hindgut neuroendocrine neoplasms - characteristics and prognosis.

Authors:  Paweł Gut; Joanna Waligórska-Stachura; Agata Czarnywojtek; Nadia Sawicka-Gutaj; Maciej Bączyk; Katarzyna Ziemnicka; Kosma Woliński; Ariadna Zybek; Jakub Fischbach; Marek Ruchała
Journal:  Arch Med Sci       Date:  2017-01-06       Impact factor: 3.318

6.  Local surgical excision versus endoscopic resection for rectal carcinoid: A meta-analysis.

Authors:  Qiaoqi Sui; Junzhong Lin; Jianhong Peng; Yujie Zhao; Yuxiang Deng; Zhizhong Pan
Journal:  J Cancer       Date:  2017-10-23       Impact factor: 4.207

Review 7.  Neuroendocrine Rectal Tumors: Main Features and Management.

Authors:  Ângela Rodrigues; Fernando Castro-Poças; Isabel Pedroto
Journal:  GE Port J Gastroenterol       Date:  2015-07-02
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.